Science Explorer Back to mapMap
Institution · Lillebaelt Hospital

Most cited papers from Lillebaelt Hospital

What are the most cited papers from Lillebaelt Hospital?

The most cited paper from Lillebaelt Hospital is "Richness of human gut microbiome correlates with metabolic markers" (Emmanuelle Le Chatelier et al., 2013), with 4,843 citations. Next come "Global strategy for asthma management and prevention: GINA executive summary" (3,258) and "Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer" (2,066).

Showing 50 of 60 papers. Every paper with more than 392 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Richness of human gut microbiome correlates with metabolic markers Emmanuelle Le Chatelier et al. · Nature Open access 27 Aug 2013 4,843
2 Global strategy for asthma management and prevention: GINA executive summary Eric Donn Bateman, Suzanne S. Hurd, Peter John Barnes et al. · European Respiratory Journal Open access 31 Dec 2007 3,258
3 Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer Gabriel N. Hortobágyi et al. · New England Journal of Medicine Open access 8 Oct 2016 2,066
4 Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps Anubha Mahajan et al. · Nature Genetics Open access115 authors Oct 2018 1,968
5 Asthma Alberto A. Papi, Christopher Edward Brightling, Søren Pedersen et al. · The Lancet 19 Dec 2017 1,825
6 Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure Lars Køber et al. · New England Journal of Medicine Open access 28 Aug 2016 1,760
7 Can Guideline-defined Asthma Control Be Achieved? Eric Donn Bateman, Homer A. Boushey, Jean Bousquet et al. · American Journal of Respiratory and Critical Care Medicine 15 Jul 2004 1,598
8 Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma Meletios Athanasios Dimopoulos et al. · New England Journal of Medicine Open access 5 Oct 2016 1,454
9 The emerging roles of circRNAs in cancer and oncology Lasse S. Kristensen, Theresa Jakobsen, Henrik Hager et al. · Nature Reviews Clinical Oncology Review 15 Dec 2021 1,409
10 Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer Rashmi Krishna Murthy et al. · New England Journal of Medicine Open access 11 Dec 2019 1,345
11 Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma Henk M. Lokhorst et al. · New England Journal of Medicine Open access 26 Aug 2015 1,132
12 The genetic architecture of type 2 diabetes Christian Fuchsberger et al. · Nature Open access301 authors 11 Jul 2016 1,129
13 The power of genetic diversity in genome-wide association studies of lipids Sarah E. Graham et al. · Nature Open access527 authors 9 Dec 2021 1,099
14 Magnetic resonance imaging for clinical management of rectal cancer: Updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting Regina G. H. Beets‐Tan, Doenja M. J. Lambregts, Monique Maas et al. · European Radiology Open access 17 Oct 2017 1,078
15 Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma Thierry T.F. Facon et al. · New England Journal of Medicine Open access 29 May 2019 1,022
16 Congenital Heart Defects in Europe Helen M. Dolk, Maria A. Loane, Ester Garne et al. · Circulation 15 Feb 2011 967
17 Daratumumab depletes CD38+ immune regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma Jakub Krejcik, Tineke Casneuf, Inger S. Nijhof et al. · Blood Open access 25 May 2016 953
18 A saturated map of common genetic variants associated with human height Loïc Yengo et al. · Nature Open access632 authors 12 Oct 2022 934
19 A summary of the new GINA strategy: a roadmap to asthma control Helen Kathryn Reddel, Eric Donn Bateman, Allan Barry Becker et al. · European Respiratory Journal Open access 23 Jul 2015 800
20 Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation Anubha Mahajan et al. · Nature Genetics Open access354 authors May 2022 774
21 Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial ROMAIN A. PAUWELS, Søren Pedersen, William W Busse et al. · The Lancet Mar 2003 772
22 Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children Lone Agertoft, Susanne S. Pedersen · Respiratory Medicine Open access May 1994 761
23 Efficacy and Safety of Inhaled Corticosteroids: New Developments Peter John Barnes, Søren Pedersen, WILLIAM W. BUSSE · American Journal of Respiratory and Critical Care Medicine Mar 1998 753
24 Continuous Lenalidomide Treatment for Newly Diagnosed Multiple Myeloma Antonio Pierangelo Palumbo et al. · New England Journal of Medicine Open access 9 May 2012 746
25 National Clinical Guidelines for non-surgical treatment of patients with recent onset low back pain or lumbar radiculopathy Mette Jensen Stochkendahl et al. · European Spine Journal Open access 20 Apr 2017 695
26 Rare and low-frequency coding variants alter human adult height Eirini Marouli et al. · Nature Open access373 authors 31 Jan 2017 665
27 The test–retest reliability of centre of pressure measures in bipedal static task conditions – A systematic review of the literature Alexander Ruhe, René Fejer, Bruce F. Walker · Gait & Posture Review Oct 2010 645
28 First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): an international, open-label, randomised, phase 3, non-inferiority trial Barbara F. Eichhorst et al. · The Lancet Oncology 23 May 2016 631
29 Exome-wide association study of plasma lipids in >300,000 individuals Charge Diabetes Working Group et al. · Nature Genetics Open access229 authors 30 Oct 2017 599
30 Genetic drivers of heterogeneity in type 2 diabetes pathophysiology Ken Suzuki et al. · Nature Open access369 authors 19 Feb 2024 598
31 Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial Miguel Martín et al. · The Lancet Oncology 626 authors 13 Nov 2017 594
32 Valproic Acid Monotherapy in Pregnancy and Major Congenital Malformations Janneke Jentink, Maria A. Loane, Helen M. Dolk et al. · New England Journal of Medicine Open access 10 Jun 2010 594
33 Operative versus nonoperative treatment of Achilles tendon rupture RENÉ CETTI, Steen-Erik Christensen, Rolf Ejsted et al. · The American Journal of Sports Medicine Nov 1993 587
34 Effect of Long-Term Treatment with Inhaled Budesonide on Adult Height in Children with Asthma Lone Agertoft, Søren Pedersen · New England Journal of Medicine Open access 12 Oct 2000 579
35 Atlas of the clinical genetics of human dilated cardiomyopathy Jan Haas et al. · European Heart Journal Open access 27 Aug 2014 578
36 Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell–Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II Trial Catherine Thiéblemont et al. · Journal of Clinical Oncology Open access 22 Dec 2022 577
37 Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer Catherine M. Phelan et al. · Nature Genetics Open access420 authors 27 Mar 2017 566
38 High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study Ane Lindegaard Appelt, John Pløen, Henrik Harling et al. · The Lancet Oncology 5 Jul 2015 564
39 Greenlandic Inuit show genetic signatures of diet and climate adaptation Matteo Fumagalli, Ida Moltke, Niels Grarup et al. · Science 18 Sep 2015 547
40 Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer Australian Cancer Study et al. · Nature Genetics Open access443 authors 27 Mar 2013 544
41 Systematic Review of Errors in Inhaler Use Joaquin Sanchis, Ignasi J. Gich, Søren Pedersen · CHEST Journal ReviewOpen access 9 Apr 2016 543
42 Second/Foreign Language Learning as a Social Accomplishment: Elaborations on a Reconceptualized SLA Alan Firth, Johannes Wagner · Modern Language Journal 29 Nov 2007 531
43 Association of Type and Location ofBRCA1andBRCA2Mutations With Risk of Breast and Ovarian Cancer Timothy R. Rebbeck et al. · JAMA Open access258 authors 7 Apr 2015 517
44 Loss-of-function mutations in SLC30A8 protect against type 2 diabetes Jason A. Flannick et al. · Nature Genetics Open access 2 Mar 2014 506
45 Sources of error in intraocular lens power calculation Thomas Olsen · Journal of Cataract & Refractive Surgery Mar 1992 502
46 Severe Exacerbations and Decline in Lung Function in Asthma Paul M. O’Byrne, Søren Pedersen, Carl Johan Lamm et al. · American Journal of Respiratory and Critical Care Medicine Open access 31 Oct 2008 493
47 Klinefelter Syndrome—A Clinical Update Kristian Ambjørn Groth, Anne H Skakkebaek, Christian Høst et al. · The Journal of Clinical Endocrinology & Metabolism 2 Nov 2012 493
48 A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality Charlotte Hyldgaard, Ole Hilberg, Alma B Pedersen et al. · Annals of the Rheumatic Diseases 14 Jun 2017 482
49 Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer ABCTB Investigators et al. · Nature Genetics Open access476 authors 23 Oct 2017 477
50 Analysis of circulating tumour DNA to monitor disease burden following colorectal cancer surgery Thomas Reinert, Lone V. Schøler, Rune Thomsen et al. · Gut Open access 4 Feb 2015 477

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.